Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Single-sachet antibiotic for uncomplicated cystitis. | First choice for simple bladder infections. |
| Body system | Antibiotics | Antibiotics |
| Drug class | Phosphonic antibiotics | Nitrofurans |
| Supply | Prescription only | Prescription onlyWHO essential medicine |
| Main uses | Uncomplicated cystitis in women, Resistant urinary tract infections (specialist) | Uncomplicated cystitis, Preventing recurrent UTIs |
| How it works | Blocks bacterial cell-wall building at an early step. | Builds up in urine and attacks bacteria there in several ways at once. |
| Starts working | Within hours | — |
| Half-life | About 4–6 hours | About 20 minutes |
| Typical adult dose | 3 g once, dissolved in water. | Modified-release 100 mg twice a day with food for 3 days (women) or 7 days (men). |
| Forms | Sachet granules, IV infusion | Capsule, Modified-release capsule, Oral suspension |
| Common side effects | Diarrhoea, Nausea, Headache, Vaginal irritation | Nausea, Headache, Dark yellow or brown urine |
| Serious side effects | Allergic reactions, C. difficile colitis | Lung reactions (cough, breathlessness), Liver injury with long-term use, Nerve damage |
| Don't take if | Severe kidney impairment; Allergy to fosfomycin | Significantly reduced kidney function (eGFR below about 45); Allergy to nitrofurantoin; Last weeks of pregnancy and babies under 3 months; G6PD deficiency |
| Alcohol | Usually no problem in moderation. No direct interaction. | Usually no problem in moderation. No direct interaction. |
| Pregnancy | Generally considered safeUsed in pregnancy with asymptomatic bacteriuria in some countries. | Use with cautionFine in early and mid pregnancy; avoid near delivery (risk of anaemia in the baby). |
| Breastfeeding | Generally considered safeSmall amounts in milk. | Use with cautionAvoid in the first weeks after birth and in G6PD-deficient infants. |
| In use since | — | 1953 |
| Brand names | United States: MonurolUnited Kingdom: MonurilIndia: Monurol, Fosfo | United States: Macrobid, MacrodantinUnited Kingdom: Macrobid, MacrodantinIndia: Niftran |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | J01XX01 | J01XE01 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker